The association between tumor mutational burden and prognosis is dependent on treatment context
出版年份 2021 全文链接
标题
The association between tumor mutational burden and prognosis is dependent on treatment context
作者
关键词
-
出版物
NATURE GENETICS
Volume 53, Issue 1, Pages 11-15
出版商
Springer Science and Business Media LLC
发表日期
2021-01-05
DOI
10.1038/s41588-020-00752-4
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Why Test for Proportional Hazards?
- (2020) Mats J. Stensrud et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Tumor mutational load predicts survival after immunotherapy across multiple cancer types
- (2019) Robert M. Samstein et al. NATURE GENETICS
- Impact of prior chemotherapy or radiation therapy on tumor mutation burden in NSCLC.
- (2019) Sushma Jonna et al. JOURNAL OF CLINICAL ONCOLOGY
- Interference of tumour mutational burden with outcome of patients with head and neck cancer treated with definitive chemoradiation: a multicentre retrospective study of the German Cancer Consortium Radiation Oncology Group
- (2019) T. Eder et al. EUROPEAN JOURNAL OF CANCER
- Correlations between microsatellite instability and the biological behaviour of tumours
- (2019) Guang Yang et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- The mutational footprints of cancer therapies
- (2019) Oriol Pich et al. NATURE GENETICS
- Tumor mutational and indel burden: a systematic pan-cancer evaluation as prognostic biomarkers
- (2019) Hao-Xiang Wu et al. Annals of Translational Medicine
- Prognostic Impact of Tumor Mutation Burden in Patients With Completely Resected Non–Small Cell Lung Cancer: Brief Report
- (2018) Yuki Owada-Ozaki et al. Journal of Thoracic Oncology
- OUP accepted manuscript
- (2018) JNCI-Journal of the National Cancer Institute
- Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients
- (2017) Ahmet Zehir et al. NATURE MEDICINE
- Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade
- (2017) Dung T. Le et al. SCIENCE
- Clonal evolution of glioblastoma under therapy
- (2016) Jiguang Wang et al. NATURE GENETICS
- Classification and characterization of microsatellite instability across 18 cancer types
- (2016) Ronald J Hause et al. NATURE MEDICINE
- Pan-cancer analysis of intratumor heterogeneity as a prognostic determinant of survival
- (2016) Luc G.T. Morris et al. Oncotarget
- Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT)
- (2015) Donavan T. Cheng et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Pan-cancer analysis of the extent and consequences of intratumor heterogeneity
- (2015) Noemi Andor et al. NATURE MEDICINE
- Genomic correlates of response to CTLA-4 blockade in metastatic melanoma
- (2015) E. M. Van Allen et al. SCIENCE
- Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer
- (2015) N. A. Rizvi et al. SCIENCE
- Progression of Lung Cancer Is Associated with Increased Dysfunction of T Cells Defined by Coexpression of Multiple Inhibitory Receptors
- (2015) D. S. Thommen et al. Cancer Immunology Research
- Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma
- (2014) Alexandra Snyder et al. NEW ENGLAND JOURNAL OF MEDICINE
- Evolutionary dynamics of cancer in response to targeted combination therapy
- (2013) Ivana Bozic et al. eLife
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started